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The role of exercise testing and stress imaging in the management of
patients with valvular heart disease (VHD) is reviewed in this article.
The American College of Cardiology/American Heart Association and
the European Society of Cardiology/European Association of Cardio-
thoracic Surgery have recently put emphasis on the role of exercise
testing to clarify symptom status and the use of stress imaging to
assess the dynamic component of valvular abnormalities and unmask
subclinical myocardial dysfunction that could be missed at rest. Recent
studies have demonstrated the incremental prognostic value of exer-
cise echocardiography for asymptomatic patients with severe aortic
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Le rôle de l’epreuve d’effort et de l’imagerie à l’effort dans la prise en
charge des patients ayant une cardiopathie valvulaire (CV) est passe
en revue dans cet article. Le American College of Cardiology et la
American Heart Associaton ainsi que la Societe Europeenne de Car-
diologie et l’Association Europeenne de Chirurgie Cardio-Thoracique
ont recemment souligne le rôle de l’epreuve d’effort pour elucider
l’etat symptomatique, et l’utilisation de l’imagerie à l’effort pour
evaluer la composante dynamique des anomalies valvulaires et
decouvrir la dysfonction myocardique sous-clinique qui pourrait ne pas
être observe au repos. De recentes etudes ont demontre la valeur
pronostique differentielle de l’echocardiographie à l’effort des patientsTransthoracic echocardiography at rest is the preferred
method for noninvasive evaluation of valvular heart disease
(VHD) because recommendations for surgery are based
mainly on the development of symptoms and hemodynamic
repercussions on the left ventricle (LV). Nevertheless, the
dynamic component of VHD, which is inﬂuenced by loading
conditions and ventriculo-arterial coupling and subclinical
myocardial dysfunction, could be missed at rest. Stress im-
aging is useful because it addresses clinical responses during
exercise testing combined with assessment of the dynamic
changes in valvular and ventricular function. Moreover, in
patients with low-ﬂow, low-gradient aortic stenosis (AS),
dobutamine stress echocardiography (DSE) is recommended
to differentiate true severe AS from pseudosevere AS.1,2 The
purpose of this article is to describe the role of exercise testingand stress imaging, mostly echocardiography, in the man-
agement of patients with VHD.
Exercise Protocols
Exercise testing is the ﬁrst choice over pharmacological
stress for risk stratiﬁcation of asymptomatic VHD patients. By
decreasing preload and afterload, pharmacological stress with
dobutamine has limited utility, except in patients with AS and
low LV ejection fraction (LVEF).3 Safety of exercise testing has
been demonstrated and complications remain low, especially in
the semisupine position with a lower risk of hemodynamic
collapse compared with treadmill.4,5 A comprehensive clinical
evaluation to rule out the presence of symptoms and to identify
potential contraindications is essential before undergoing ex-
ercise testing. Contraindications to exercise testing include:
clear indications for valve surgery (ie, symptomatic severe AS or
mitral stenosis [MS], uncontrolled hypertension or arrhyth-
mias, physical/mental disability, or systemic disease with the
inability to adequately exercise).6 A symptom-limited exercise
test performed under supervision with the goal of reaching at
least 85% of the age-predicted heart rate is recommended.
Patients should continue taking their usual medication(s),d by Elsevier Inc. All rights reserved.
regurgitation. In patients with low-ﬂow, low-gradient aortic stenosis,
dobutamine stress echocardiography is recommended to differentiate
true severe from pseudosevere aortic stenosis. Data on the prognostic
value of stress echocardiography in aortic regurgitation and functional
mitral regurgitation are less robust. Data are sparse on the use of
stress imaging in right-sided VHD, however recent studies using stress
cardiovascular magnetic resonance imaging offer some prognostic
information. Although the strongest recommendations for surgical
treatment continue to be based on symptom status and resting left
ventricular repercussions, stress imaging can be useful to optimize risk
stratiﬁcation and timing of surgery in VHD. Randomized clinical trials
are required to conﬁrm that clinical decision-making based on stress
imaging can lead to improved outcomes.
asymptomatiques atteints d’une stenose aortique grave, d’une stenose
mitrale moderee à grave et de regurgitation mitrale primaire grave.
Chez les patients atteints d’une stenose aortique à faible gradient et à
bas debit, l’echocardiographie avec dobutamine est recommandee
pour differencier la veritable stenose aortique sevère de la stenose
aortique aortique pseudosevère. Les donnees sur la valeur pronostique
de l’echocardiographie à l’effort lors de regurgitation aortique et de
regurgitation mitrale fonctionnelle sont moins ﬁables. Les donnees sur
l’utilisation de l’imagerie à l’effort lors de CV du côte droit sont rares.
Cependant, de recentes etudes utilisant l’imagerie par resonance
magnetique cardiovasculaire offrent certaines informations sur le
pronostic. Bien que les meilleures recommandations de traitement
chirurgical soient encore fondees sur l’etat symptomatique et les
repercussions au repos du ventricule gauche, l’imagerie à l’effort peut
être utile pour optimiser la stratiﬁcation du risque et le moment de la
chirurgie lors de CV. Des essais cliniques aleatoires sont necessaires
pour conﬁrmer si la prise de decision clinique fondee sur l’imagerie à
l’effort entraîne l’amelioration des resultats.
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Exercise and Stress Imaging in VHDbecause abnormal exercise testing results while patients are
taking suboptimal therapy might be confusing for management
decisions.
Exercise stress echocardiography (ESE) in VHD should
be performed by an experienced sonographer or cardiolo-
gist. Treadmill or semisupine bicycle exercise testing can be
performed. Treadmill exercise is more commonly used in
North America and is realized according to the American
College of Cardiology/American Heart Association (ACC/
AHA) practice guidelines using a modiﬁed Bruce protocol.7
However, this technique allows imaging only after exercise,
limiting the accuracy of measurements. In contrast, semi-
supine ergocycle with a tilting table, which is the preferred
approach in Europe, is more physiologic and permits
optimal image acquisition during each step of exercise
testing.3
Blood pressure, heart rate, 12-lead electrocardiography,
and echocardiographic parameters related to the valve, the LV,Table 1. Exercise stress echocardiography protocol according to valvular he
Aortic stenosis
Baseline
25 W Mean aortic gradient
Aortic valve area
CW aortic valve





TDI PW mitral annulus




CW, continuous-wave Doppler; EROA, effective regurgitant oriﬁce area; FPS, fr
isovelocity surface area; PW, pulsed-wave Doppler; RVol, regurgitant volume; SPAP,
regurgitation.
*With emphasis on parameters listed at 25 W.
yMeasured before E and A wave fusion.and the hemodynamic consequences (eg, pulmonary arterial
pressure) are recorded at rest, at each step of the exercise test
and during recovery (Table 1). The workload should be
adjusted for each patient (ie, beginning at 50 W with an
increase of 25 W every 2 minutes for a young patient with
preserved LV function vs starting at 25 W with an increase of
10 W every 2 minutes for an older patient with low LVEF).
Symptoms should be assessed regularly during the examina-
tion. Exercise testing should be interrupted when the target
heart rate is reached or if the patient presents typical chest
pain, limiting breathlessness, dizziness, hypotension (decrease
in systolic blood pressure  20 mm Hg), signiﬁcant ven-
tricular arrhythmia, or muscular exhaustion. The test is
considered positive if the patient encounters  1 of the
following criteria: angina, limiting dyspnea, syncope or near-
syncope,  2 mm horizontal or downsloping ST segment
depression, decrease or < 20 mm Hg increase in systolic
blood pressure, or complex ventricular arrhythmias.6art disease















onal grey-scale images in 4, 2, and 3 chamber views (> 60 FPS)
ame per second; LV, left ventricle; MR, mitral regurgitation; PISA, proximal
systolic pulmonary artery pressure; TDI, tissue Doppler imaging; TR, tricuspid
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Volume 30 2014Aortic Stenosis
Exercise testing
AS is a highly and increasingly prevalent condition which
has become a major health concern.8 Characteristically, pa-
tients present a long latent asymptomatic period in which the
risk of sudden death is low, even with severe AS (ie, peak
aortic velocity  4 m/s, mean transaortic gradient [MTAG] 
40 mm Hg, and aortic valve area [AVA]  1.0 cm2 or  0.60
cm2/m2). However, the risk of sudden death increases
dramatically when symptoms appear, justifying the class I
recommendation for aortic valve replacement (AVR).1,2,9
Symptomatic status can be difﬁcult to establish, especially in
elderly patients, because they might minimize or deny their
symptoms or reduce their level of physical activity to avoid
them. Exercise testing can be useful to unmask symptoms in
patients with severe AS. Approximately one-third of patients
who claim to be asymptomatic develop symptoms with ex-
ercise testing.10,11 For this reason, exercise testing is strongly
advocated by the European Society of Cardiology/European
Association of Cardiothoracic Surgery (ESC/EACTS) (class I
recommendation)2 whereas the ACC/AHA suggest that it
might be considered (class IIa recommendation) in asymp-
tomatic patients with severe AS.1 However, interpretation of
exercise testing could be limited in the elderly population.
Positive predictive value in patients > 70 years old has been
shown to be signiﬁcantly lower than in younger patients (56%
compared with 79%), with similar negative predictive
values.11 According to this, a negative exercise test in an
elderly patient is reassuring, but a positive exercise test might
lack in speciﬁcity because of frequent comorbidities.
Symptom-limited stress testing, with appropriate supervi-
sion and monitoring, has been demonstrated to be safe in
severe AS and to add important prognostic value.12 An exercise
test is considered normal if the patient remains asymptomatic
(no angina, limiting dyspnea at low workload [ie, during the
ﬁrst steps of exercise], syncope or near-syncope) during the test
with an adequate increase in systolic blood pressure (> 20 mm
Hg) and absence of complex ventricular arrhythmias. A posi-
tive exercise test has been shown to predict the rapid onset of
symptoms and cardiac death.10 Dizziness has the highest
positive predictive value for the development of symptoms
during the following year. The occurrence of rapidly reversible
dyspnea at high workloads should, however, not be interpreted
as abnormal. Of note, ST-depression (> 2 mm, horizontal or
downsloping) during exercise with AS does not seem to
improve the predictive accuracy of the test, particularly in
patients with concomitant coronary artery disease (CAD).11Exercise stress echocardiography
Changes in mean aortic gradient. Asymptomatic patients
with severe AS and normal LV function undergoing early
AVR might have better outcomes than those with medical
treatment.13 However, although AVR is safe and widely
performed, the rates of operative mortality and valve-related
complications are not null. Therefore, the identiﬁcation of
prognostic factors could help to determine the patients who
might beneﬁt the most from early elective surgery. ESE has
demonstrated an additive prognostic value over clinicalﬁndings, resting echocardiography, and exercise testing. An
increase in MTAG by  18-20 mm Hg (Fig. 1) was associ-
ated with an increased risk of cardiac-related events.14,15 This
increase in MTAG most likely reﬂects the presence of a more
severe AS with a noncompliant, rigid aortic valve (Table 2).16
Changes in LV function. Assessment of LV function during
exercise also provides incremental prognostic information.
Limited contractile reserve (ie, a decrease or a limited increase
in LVEF) is associated with an abnormal hemodynamic
response to exercise, development of symptoms, and cardio-
vascular death.17,18 Exercise-induced LV dysfunction might
represent a more advanced disease state. This could be
explained by afterload mismatch and exercise-exhausted coro-
nary ﬂow reserve leading to subendocardial ischemia and more
extensive myocardial ﬁbrosis.25 Standard LVEF measurements
are insensitive to detect early forms of LV systolic dysfunction.
Assessment of longitudinal LV function seems to be a more
powerful parameter in predicting the occurrence of symptoms,
exercise intolerance, and outcomes in AS.26,27 Longitudinal
function can be studied using tissue Doppler imaging with
pulsed-wave Doppler at the mitral annulus measuring Sa ve-
locities or using 2-dimensional speckle tracking analyzing
global longitudinal strain (GLS). Donal et al. reported that LV
contractile reserve assessed with GLS is predominantly altered
in patients with an abnormal exercise test (Table 2).19
Left ventricular ﬁlling pressure estimation and systolic
pulmonary artery pressure. Other ﬁndings might explain
the occurrence of symptoms in patients with severe AS, such
as increase of LV ﬁlling pressure or systolic pulmonary artery
pressure (SPAP) with exercise. At rest, a cutoff value of the
ratio of early diastolic mitral inﬂow velocity to early diastolic
annulus velocity (E/Ea) > 13 has been reported to identify an
LV end-diastolic pressure > 15 mm Hg with a sensitivity of
93% and a speciﬁcity of 88% in moderate-severe AS.28 Ex-
ercise values have yet to be validated in AS patients. Of note,
E/Ea ratio should be measured before E and A wave fusion,
which appear at high heart rates.
Pulmonaryhypertension (PHT) couldbeunmaskedwithESE
(Fig. 1). In a recent prospective study, exercise-induced PHT,
deﬁned as SPAP > 60 mm Hg, was associated with a 2-fold
increased risk of cardiac events at 3-year follow-up in asymp-
tomatic patients with severe AS and preserved LVEF (Table 2).20
Impact on clinical decision-making
 Current ESC/EACTS and ACC/AHA guidelines
recommend AVR in asymptomatic patients with severe
AS who present symptoms during exercise testing (ESC/
EACTS, class I; ACC/AHA, class IIa) or a decrease in
blood pressure below baseline (ESC/EACTS, class IIa;
ACC/AHA, class IIa).1,2
 The ESC/EACTS recently added recommendation
for AVR based on ESE, such as the increase of MTAG
by > 20 mm Hg during exercise (class IIb).2
 ESE might be useful to improve risk stratiﬁcation and
identify patients who might beneﬁt from early surgery.
Prospective clinical trials are needed to support the use
of exercise-induced echocardiographic changes, such as
increase in MTAG, limited LV contractile reserve, or
PHT as clear indications for AVR (Fig. 2A).
Figure 1. Doppler ﬁndings in an asymptomatic severe aortic stenosis patient at rest (left panels) and at exercise (right panels). A signiﬁcant
increase of MTAG  20 mm Hg (A) and exercise-induced PHT (B) are shown, which represent 2 risk factors for cardiac events. AV, aortic valve;
AVA, AV area; AV Env. Ti, aortic time interval; HR, heart rate; maxPG, maximal pressure gradient; meanPG, mean pressure gradient; MTAG, mean
transaortic gradient; PHT, pulmonary hypertension; TR, tricuspid regurgitation; TTG, transtricuspid gradient; Vmax, maximal velocity; Vmean, mean
velocity; VTI, velocity time integral.
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Dobutamine stress echocardiography
According to guidelines, ‘‘Low-ﬂow, low-gradient AS’’ with
LV dysfunction is deﬁned as a small AVA (< 1.0 cm2 or< 0.6
cm2/m2) with low MTAG (< 30-40 mm Hg), low LVEF
(< 40%) and low ﬂow state (stroke volume index < 35 mL/
m2).1,2 This condition is observed in approximately 5%-10%
of patients with severe AS and can correspond to 2 different
situations: true severe AS with depressed LVEF caused by
excessive afterload and concomitant myocardial disease, or
pseudosevere AS with myocardial contractile dysfunction
leading to reduced valve opening.29 DSE has been demon-
strated to be useful to differentiate true severe from pseudo-
severe AS and to assess the presence and extent of ﬂow
reserve.30-33 Flow reserve is calculated as follows: ﬂow reserve
(%) ¼ (SVpeak e SVrest)/SVrest  100 where SV (stroke vol-
ume) ¼ 0.785  LVOT (left ventricular outﬂow tract)
diameter2  LVOT TVI, respectively, at rest and at peak
stress. DSE is a class IIa indication for this purpose according
to the current ESC/EACTS and ACC/AHA guidelines.1,2 The
main objective of DSE is to increase the transvalvular ﬂow rate
using a low-dose protocol with gradual increments of dobut-
amine (5 mg/kg/min) at 5-8 minute intervals to achieve a
steady state and avoid tachyarrhythmia or ischemia.3 The end
points for terminating infusion of dobutamine are: (1) heartrate > 220 e age; (2) systolic blood pressure < 80 mm Hg or
> 220 mm Hg; (3) ischemia detected using electrocardiogram
(> 5 mm ﬂat or downsloping ST depression); (4) complex
ventricular arrhythmias or rapid new atrial arrhythmias; (5)
breathlessness, angina, dizziness, or syncope; and (6)
maximum dose reached (20 mg/kg/min).34-36
True severe vs pseudosevere AS. True severe AS (Fig. 3) is
deﬁned as an increase in MTAG to > 40 mm Hg, a small
change in AVA (increase < 0.3 cm2) and/or an AVA  1.0-
1.2 cm2, and particularly the presence of ﬂow reserve (ie, >
20% increase of stroke volume) with low-dose dobutamine.2
Presence of both criteria (true AS and presence of ﬂow
reserve) will help to identify patients who will beneﬁt the most
from AVR in terms of long-term survival and improvement of
functional status.32 Pseudosevere AS is characterized by a
signiﬁcant increase in AVA (increase  0.3 cm2) and/or an
AVA > 1.2 cm2, and an MTAG remaining < 40 mm Hg,
explained by the recruitment of LV myocytes leading to
greater opening of the “not severely” stenotic aortic valve with
low-dose dobutamine. The prevalence of pseudosevere AS is
considered to be between 20% and 30% of patients with low-
ﬂow, low-gradient AS.29 These patients should be treated with
aggressive heart failure therapy and they might require AVR if
medical therapy fails to improve their condition and/or if the
stenosis progresses to the severe stage.37
Table 2. Main studies addressing exercise echocardiography in asymptomatic patients with aortic stenosis or primary mitral regurgitation and
preserved LV function
Type of study Patient n Inclusion criteria End points Predictors of outcome Reference
Aortic stenosis
Prospective
FU ¼ 15  7 months
69 AVA  1 cm2 Occurrence of symptoms, heart failure,
AVR, cardiac death




FU ¼ 20  14 months
186 AVA < 1.5 cm2
AVAi < 0.9 cm2/m2
Occurrence of AVR or cardiac death Exercise-induced increase in MTAG >
20 mm Hg
15
Prospective 128 AVA  1cm2 Abnormal exercise test Exercise-induced increase in MTAG 
17 mm Hg and decrease in LVEF
17
Prospective
FU ¼ 11 months
50 AVA1cm2 Occurrence of symptoms or AVR Exercise-induced decrease in LVEF 18
Case-control 207 AVA  1.2 cm2 Abnormal exercise test Higher exercise increases in MTAG
and smaller changes in LV GLS
19
Prospective
FU ¼ 19  11 months
105 AVAi < 0.6 cm2/m2 Occurrence of AVR or cardiovascular
death





FU ¼ 22  13months
61 EROA > 20 mm2 and
RVol > 30 mL
Occurrence of symptoms Exercise-induced increase in EROA >
10 mm2 and RVol > 15 mL
21
Prospective
FU ¼ 19  14 months
78 EROA > 20 mm2 and
RVol > 30 mL




FU ¼ 27  15 months
196 EROA > 20 mm2 and
RVol > 30 mL
Occurrence of MVR Exercise-induced RV dysfunction
(TAPSE < 19 mm) and exercise
PHT (SPAP > 54mmHg)
23
Prospective
FU ¼ 24  21 months
115 EROA > 20 mm2 and
RVol > 30 mL
Occurrence of MVR, cardiac death,
heart failure
Exercise-induced increase of LV GLS
< 2%
24
AVA, aortic valve area; AVAi, indexed aortic valve area; AVR, aortic valve replacement; EROA, effective regurgitant oriﬁce area; FU, follow-up; GLS, global
longitudinal strain; LV, left ventricular; LVEF, left ventricular ejection fraction; MTAG, mean transaortic gradient; MVR, mitral valve replacement; PHT, pul-
monary hypertension; RV, right ventricular; RVol, regurgitant volume; SPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion.
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an increase < 20% of stroke volume using low-dose dobut-
amine, is present in 30%-40% of patients with a low ﬂow
state and could be explained by afterload mismatch (imbal-
ance between AS severity and myocardial reserve), myocardial
ﬁbrosis, or concomitant CAD.29 Patients without ﬂow reserve
present much greater operative mortality (22%-32%) during
AVR than those with ﬂow reserve (5%-8%).29,32,38 Moreover,
lack of ﬂow reserve has been identiﬁed as a predictor for
surgical and 30-day mortality.32 Despite high surgical mor-
tality, 5-year mortality was signiﬁcantly lower after AVR
(31%) compared with medical therapy alone (87%) in pa-
tients without ﬂow reserve.38 Also, the lack of ﬂow reserve
could not reliably predict the absence of LVEF recovery after
surgery because 65% of patients with no ﬂow reserve had a
postoperative increase in LVEF of > 10%.39 According to
these data, absence of ﬂow reserve should not be considered
an absolute contraindication for AVR.38,39 Nevertheless, in
patients without ﬂow reserve, stenosis severity often remains
indeterminate at the outset of DSE and another imaging
modality, such as aortic calciﬁcation quantiﬁcation using
computed tomography, might be needed to conﬁrm stenosis
severity and indication for surgery.40,41Projected AVA. A limitation of DSE is that the increase in
transvalvular ﬂow achieved might vary widely from patient to
patient. Hence, interpretation of the AVA and MTAG
changes without consideration of the relative change in
transvalvular ﬂow might lead to ambiguous results. A way to
overcome this limitation is to compare AVA at a standardized
mean transvalvular ﬂow rate (Q) of 250 mL/s. This novelparameter, called the projected AVA (AVAproj), has been
shown to be more closely related to actual AS severity and
survival than traditional DSE parameters. The AVAproj is
calculated as follows: AVAproj ¼ (AVApeak  AVArest)/
(Qpeak  Qrest)  (250  Qrest) þ AVArest, where AVArest
and Qrest, and AVApeak and Qpeak are AVA calculated by
continuity equation and Q by dividing SV (mL) by LV
ejection time (s) at rest and at peak DSE, respectively.34,35,42
An AVAproj  1.0 cm2 is considered to be severe.
Impact on clinical decision-making
 In symptomatic patients with low-ﬂow, low-gradient AS
and low LVEF, AVR is recommended after the
demonstration using DSE of true severe AS with evi-
dence of ﬂow reserve (ESC/EACTS, class IIa; ACC/
AHA, class IIa).1,2
 AVR might also be considered in true severe AS patients
without ﬂow reserve after careful evaluation of other
comorbidities, particularly CAD (ESC/EACTS, class
IIb; ACC/AHA, class IIa).2
 Initial medical therapy with close follow-up is preferred
in patients with pseudosevere AS.37 Surgery could be
reconsidered if there is no clinical improvement or if
deterioration occurs. The importance of the imbalance
between the degree of AS severity and myocardial
dysfunction should be regularly assessed and AVR might
be considered, arguing that moderate AS could have a
similar hemodynamic effect on a failing LV as a severe
AS on a preserved LV. In cases of severe myocardial
impairment, cardiac transplantation might be considered
an option in selected patients (Fig. 2B).29
Figure 2. Impact of exercise testing and stress echocardiography in AS on clinical decision-making: asymptomatic severe AS (A) and symptomatic
low-ﬂow, low-gradient AS (B). Symptoms include angina, limiting dyspnea, syncope or near-syncope. Abnormal BP is deﬁned as a decrease or < 20
mm Hg increase in systolic BP, and limited contractile reserve as a decrease or limited increase (< 4%) in LVEF. * Patients without criteria of worse
prognosis could receive usual follow-up (ie, every 6 months in ESC/EACTS guidelines or 1 year in ACC/AHA guidelines) vs close follow-up (ie, every 3-
6 months). ** Only in patients with LV dysfunction. ACC/AHA guidelines do not deﬁne different levels of recommendations according to presence or
absence of ﬂow reserve. ACC/AHA, American College of Cardiology/American Heart Association; AS, aortic stenosis; AVA, aortic valve area; AVA proj,
projected AVA; BP, blood pressure; EACTS, European Association of Cardiothoracic Surgery; ESC, European Society of Cardiology; LV, left ventricular;
LVEF, LV ejection fraction; MTAG, mean transaortic gradient; SPAP, systolic pulmonary artery pressure; SV, stroke volume.
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Figure 3. Doppler measurements in a symptomatic patient with low-ﬂow/low-gradient AS. Rest ﬁndings (left panels) show low-ﬂow with a SVi of 28
mL/m2 and low gradient with an MTAG of 19 mm Hg. At peak dobutamine (right panels), the presence of LV ﬂow reserve (26.5% increase of SVi) (A),
and true severe AS (MTAG ¼ 39 mm Hg and AVA  1.0 cm2 (B) are shown. AS, aortic stenosis; AV, aortic valve; AVA, AV area; Dopp, Doppler; Env.
Ti, aortic time interval; HR, heart rate; LV, left ventricular; LVCO, LV cardiac output; LVCI, LV cardiac index; LVOT, LV outﬂow tract; LVSI, LV stroke
index; LVSV, LV stroke volume; maxPG, maximal pressure gradient; meanPG, mean pressure gradient; MTAG, mean transaortic gradient; SVi, stroke
volume index; Vmax, maximal velocity; Vmean, mean velocity; VTI, velocity time integral.
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preserved LVEF
Some patients with severe AS based on calculated AVA
might paradoxically present a low-ﬂow, low-gradient con-
dition despite preserved LVEF. This condition, called
paradoxical low-ﬂow, low-gradient severe AS, is deﬁned as
LVEF  50%, stroke volume index  35 mL/m2, MTAG
< 40 mm Hg, and AVA < 1 cm2 or < 0.6 cm2/m2, and
could be present in up to 25% of patients with severe AS
and preserved LVEF.43 This pattern seems to represent a
more advanced stage of the disease with a reduced 5-year
survival compared with patients with normal-ﬂow, high--
gradient severe AS (64% vs 82%, respectively). AVR is
associated with improved survival compared with medical
therapy in these patients.44 This condition is often mis-
diagnosed, which leads to the inappropriate delay of sur-
gery. As for patients with low LVEF, low-dose DSE might
be useful to unmask pseudosevere AS caused by the low-
ﬂow state from true severe AS. Among DSE parameters
of AS severity, AVAproj  1 cm2 seems to have the best
accuracy to differentiate true from pseudosevere AS and to
predict the risk of adverse cardiac events.45 Moreover,
severe aortic calciﬁcation identiﬁed using computed to-
mography might also be helpful to differentiate true vspseudosevere AS. A threshold of 1651 arbitrary units (AU)
or more speciﬁcally, 1274 AU for women and 2065 AU
for men has been associated with a good sensitivity and
speciﬁcity ( 80%) for the diagnosis of true severe
AS.40,41 Some have suggested that vasodilatory stress
catheterization using nitroprusside could be used to iden-
tify true severe AS in patients with paradoxical low-ﬂow,
low-gradient AS.46 More studies are needed to conﬁrm
the usefulness of this approach. Recent ESC/EACTS and
ACC/AHA guidelines included a class IIa recommendation
(Fig. 2B) for AVR in symptomatic patients with para-
doxical low-ﬂow, low-gradient severe AS after careful
conﬁrmation of true severe AS.1,2Aortic Regurgitation
Exercise testing
The occurrence of symptoms in patients with severe aortic
regurgitation (AR) is associated with an excessive mortality
rate47 and represents a strong indication for AVR.1,2 Exercise
testing is reasonable to unmask symptoms and assess func-
tional capacity in patients with severe AR who present
equivocal symptoms.
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angiography
Few studies, including those with small numbers of pa-
tients, have evaluated the prognostic value of ESE in AR and,
routine clinical use is not recommended. If performed, the
main goal should be to unmask subclinical LV dysfunction
during exercise using standard LVEF measurement or LV
longitudinal function assessment with tissue Doppler imaging
or 2-dimensional strain.48 The demonstration of a limited LV
contractile reserve could help to identify patients who might
develop progressive LV dysfunction during medical treatment
or no improvement in LVEF after AVR.49 DSE is almost
systematically associated with a decrease in AR severity; it
might, however, be useful for the assessment of LV contractile
reserve or inducible ischemia. In a cohort of 29 patients with
severe AR, preoperative exercise-induced change in LVEF
measured using radionuclide ventriculography, compared
with preoperative LVEF at rest, has been shown as a predictor
of postoperative LV performance during exercise.50
Impact on clinical decision-making
 Although ESE is not recommended for the routine man-
agement of AR, measurement of contractile reserve might
be useful to unmask subclinical myocardial dysfunction,
especially in patients with borderline values of LVEF
(50%-55%) or end-systolic diameter (near 50 mm or 25
mm/m2), andmight help optimize the timing of surgery.51Mitral Stenosis
Stress echocardiography
The clinical utility of stress imaging for MS is limited to
echocardiography. The ACC/AHA and ESC/EACTS guide-
lines recommend stress echocardiography in patients who
present a discrepancy between symptoms and severity of MS
at rest: (1) to unmask symptoms in asymptomatic patients
with at least moderate MS (< 1.5 cm2), especially in elderly
and/or sedentary patients; and (2) to evaluate the hemody-
namic effect of exercise in patients with limiting symptoms,
but mild MS.1,2 Stress echocardiography can provide impor-
tant information regarding exercise-induced symptoms,
functional capacity, valve function, and its hemodynamic
consequences. Exercise stress, being more physiologic, is
preferred. Nevertheless, DSE might also be performed and
seems to lead to similar hemodynamic changes in mean
transmitral gradient (MTMG) and SPAP.52 Safety and feas-
ability of DSE have been demonstrated in 53 patients with
rheumatic MS.53 DSE was started at 10 ug/kg/min for 5
minutes and increased by 10 ug/kg/min every 3 minutes to a
maximal dose of 40 ug/kg/min. DSE should be performed
during usual medical therapy, including b-adrenergic
antagonists.53
Changes in mitral gradient and SPAP. Data regarding the
use and prognostic value of stress echocardiography in MS are
limited. With DSE in patients with at least moderate MS, the
increase of MTMG at peak dose was the best predictor of
adverses events (hospitalizations, acute pulmonary edema, or
supraventricular arrhytmias) during follow-up (60.5  11months). A cutoff value of 18 mm Hg allowed the best
detection of events (90% sensitivity and 87% speciﬁcity).53
Exercise testing revealed the presence of symptoms in 46%
of 48 “asymptomatic” patients with moderate-severe MS. Of
interest, MS severity and SPAP at rest were not different
between patients who developed dyspnea during exercise
compared with truly asymptomatic patients. The magnitude
of exercise-induced increase in MTMG and relative SPAP
(exercise/rest SPAP) were signiﬁcantly greater and more
rapid in patients with positive exercise testing (Fig. 4). Also,
the cut point of 60 mm Hg for exercise SPAP was not
signiﬁcantly related to the occurence of symptoms, but an
early exercise-induced increase in relative SPAP  90% at 60
W was associated with a > 2-fold increase in the risk of
developping dyspnea or to require mitral valve intervention
during follow-up. These observations suggest that the evalu-
ation of changes in MTMG and the pattern of SPAP pro-
gression, especially during the ﬁrst stage of exercise, play an
important role in the evaluation of exercise tolerance and
underline the beneﬁts of studying hemodynamic changes at
every stage of exercise, rather than simply comparing rest and
peak exercise values.54
Atrioventricular compliance. Resting and particularly ex-
ercise SPAP could be dramatically different in patients with
comparable mitral valve areas but different atrioventricular
(AtV) compliance. Patients with low AtV compliance
( 4 mL/mm Hg) represent an important clinical entity in
which symptoms correspond to severe increases in SPAP
during stress.55,56 In a study by Brochet et al., AtV compli-
ance was the only independent predictor, among multiple
resting echocardiographic parameters, of exercise dyspnea, and
an important determinant of functional impairment.54 Net
AtV compliance can be calculated from the ratio of effective
mitral valve area (MVA) (continuity equation) and the E-wave
downslope: AtV compliance (mL/mm Hg) ¼ 1270 (MVA
[cm2]/E-wave downslope [cm/s]).55
Impact on clinical decision-making
 When valve anatomy is suitable, percutaneous valvulo-
plasty may be considered in symptomatic patients with
mildMS (MVA> 1.5 cm2) and increase inMTMG> 15
mm Hg with exercise (ACC/AHA, class IIb).1
 In asymptomatic patients with signiﬁcant MS (MVA <
1.5 cm2), the presence of exercise PHT (SPAP > 60 mm
Hg) or increase in MTMG > 15 mm Hg should lead to
close follow-up.
 Because of the greater operative risk and potential long-
term complications with a prosthetic valve, stress
echocardiography-related indications do not apply to
mitral valve replacement (Fig. 5A).
Primary Mitral Regurgitation
Exercise, stress echocardiography, and radionuclide
angiography
Primary or organic mitral regurgitation (MR) is a dynamic
process. Exercise testing might identify patients with unrec-
ognized symptoms or demystify symptoms that are out of
proportion with resting MR severity. Exercise capacity is
Figure 4. Doppler assessment of an asymptomatic patientwithmoderate rheumaticmitral stenosis and normal SPAPat rest (left panels). At exercise (right
panels), a signiﬁcant increase in MTMG (A) and PHT (B) are shown. HR, heart rate; maxPG, maximal pressure gradient; meanPG, mean pressure gradient;
MTMG, mean transmitral gradient; MV, mitral valve; MVA, MV area; PHT, pulmonary hypertension; SPAP, systolic pulmonary artery pressure; TR, tricuspid
regurgitation; TTG, trans-tricuspid gradient; Vmax, maximal velocity; Vmean, mean velocity; VTI, velocity time integral.
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patients with severe MR and is associated with worse
outcome, regardless of resting MR severity.57 ACC/AHA
guidelines recommend ESE for asymptomatic severe MR
(effective regurgitant oriﬁce area [EROA]  40 mm2 and
regurgitant volume [RVol]  60 mL) to establish symptom
status and exercise tolerance, and for symptomatic patients
where there is a discrepancy between symptoms and the
severity of MR at rest (class IIa).1 ESE in a semisupine posi-
tion should be used to evaluate primary MR. DSE is not
useful because of the hemodynamic effects leading to de-
creases of preload and afterload.
Changes in MR severity, SPAP, and right ventricular
function. In chronic asymptomatic moderate-severe primary
MR, a marked exercise-induced increase in MR severity (in-
crease of EROA  10 mm2 and RVol  15 mL) was found in
one-third of patients and > 50% of patients with moderate
MR at rest developed severe MR during exercise. The
magnitude of this increase was well correlated with exercise-
induced PHT, but unrelated to resting MR severity.21Consequently, the main harmful consequence of dynamic
MR is the development of exercise-induced PHT. Deﬁned as
SPAP > 60 mm Hg with exercise, it was present in 46% of
patients and associated with a markedly reduced 2-year
symptom-free survival. Moreover, exercise SPAP was a more
accurate predictor of progression to symptoms compared with
resting SPAP. The best cutoff value of exercise PHT (> 56
mm Hg) was close to that proposed by guidelines (> 60 mm
Hg). In contrast, the best cutoff value of SPAP at rest (> 36
mm Hg) was much lower than the value suggested by
guidelines (> 50 mm Hg).22 Kusunose et al. assessed the role
of right ventricular (RV) function during exercise using
tricuspid annular plane systolic excursion (TAPSE). They
showed that exercise TAPSE was a readily available marker
and an independent predictor of time to surgery. Patients with
concomitant exercise-induced RV dysfunction (TAPSE < 19
mm) and exercise PHT (SPAP > 54 mm Hg) had the worse
prognosis. In multivariate analysis, resting LV strain, RV end-
systolic area, exercise SPAP, and exercise TAPSE provided the
best predictive model of outcome (Table 2).23 Similarly,
assessment of RV function at exercise using radionuclide
Figure 5. Impact of exercise testing and stress echocardiography on clinical decision-making in mitral valve disease: asymptomatic moderate-severe
and asymptomatic mild MS (A), and asymptomatic primary severe MR (B). * Patients without criteria for worse prognosis could receive usual follow-up
(every 6 months) vs close follow-up (every 3 months). ACC/AHA, American College of Cardiology/American Heart Association; EROA, effective
regurgitant oriﬁce area; ESC, European Society of Cardiology; GLS, global longitudinal strain; LVEF, left ventricular ejection fraction; MR, mitral
regurgitation;MS,mitral stenosis;MTMG,mean transmitral gradient;MVA,mitral valve area; RVol, regurgitant volume;SPAP, systolic pulmonary artery
pressure.
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and RV function at rest has been shown to predict subsequent
development of surgical indications in patients with a decrease
in RV ejection fraction during exercise.58
Changes in LV function. ESE is useful to unmask sub-
clinical latent LV dysfunction with MR, especially in cases
with borderline LVEF (60%-65%) or LV end-systolic diam-
eter (near 40 mm or 22 mm/m2).4,59 Absence of contractile
reserve, deﬁned as the inability to increase LVEF by > 4% or
an end-systolic volume index > 25 cm3/m2 at exercise, has
been associated with postoperative LV dysfunction after mitral
valve surgery, and progressive deterioration of LV function inmedically treated patients.60 New tools, such as GLS
measured using 2-dimensional speckle-tracking at rest and
during exercise, can be used to detect limited contractile
reserve and predict postoperative LV dysfunction. GLS
measured during exercise has been shown to have greater
sensitivity and speciﬁcity than exercise LVEF in predicting LV
dysfunction (LVEF < 50%) after mitral valve surgery.61
Moreover, the absence of LV contractile reserve using LV
GLS (exercise-induced increase < 2%) was signiﬁcantly
associated with higher exercise B-type natriuretic peptide
levels and a 2-fold increase in risk of cardiac events. In
contrast, there was no signiﬁcant difference in outcome when
LV contractile reserve was assessed using LVEF (Table 2).24,62
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 In asymptomatic patients with severe primary MR and
preserved LVEF, the ESC/EACTS guidelines advocate
that surgery is deemed reasonable in patients with SPAP
 60 mm Hg during exercise (class IIb
recommendations).2
 In the debate opposing “early surgery” vs “watchful
waiting,” ESE might be relevant for risk stratiﬁcation
and estimation of prognosis. Patients with impaired
exercise capacity, marked exercise-induced increase in
MR or SPAP (as noted herein) and those without LV
contractile reserve represent a subset of high-risk patients
in whom “early” surgery could be indicated, particularly
in a high-volume surgical centre with excellent rates of
durable mitral valve repair success.4 Conversely,
asymptomatic severe MR without any signs of PHT or
LV dysfunction during exercise could be safely followed-
up clinically (Fig. 5B).Secondary Mitral Regurgitation
Stress echocardiography
Mitral valve function is intimately related to LV function
and is highly dynamic. Transient myocardial ischemia oc-
casionally causes secondary MR. This can be identiﬁed using
ESE and often implies signiﬁcant CAD (usually left
circumﬂex or right coronary stenosis).63 In ischemic or
dilated cardiomyopathy, complex LV remodelling, including
mitral valve and LV geometry deformation, leads to an
imbalance between increased tethering forces and reduced
closing forces resulting in signiﬁcant MR and worse prog-
nosis.64,65 ESC/EACTS guidelines emphasize the role of ESE
to unmask signiﬁcant dynamic MR in patients with LV
systolic dysfunction.2 ESE is recommended in patients with
LV dysfunction and: (1) exertional dyspnea out of propor-
tion with the resting MR severity or LVEF; (2) acute pul-
monary edema without an obvious cause66; (3) moderate
MR before surgical revascularization; and (4) for risk strati-
ﬁcation of mortality and heart failure.36 ESE remains the best
modality to evaluate the dynamic component of secondary
MR, because DSE leads to confounding effects caused by
reduction in loading conditions. DSE might, however, be
useful to evaluate myocardial viability and/or ischemia when
coronary revascularization concomitant with mitral surgery is
contemplated.
Changes in MR severity
In patients with chronic secondary MR, an EROA  20
mm2 at rest should be considered severe because of its effect
on cardiac mortality.59 Resting MR severity cannot predict the
magnitude of exercise-induced increase of MR.67 In a cohort
of 161 patients with at least mild secondary MR prospectively
followed up for 35  11 months, an exercise-induced increase
in EROA  13 mm2 predicted mortality and hospitalization
for heart failure.68 Exercise-induced increases in EROA and
exercise SPAP (Fig. 6) were independently associated with the
occurrence of acute pulmonary edema.66 The prognostic sig-
niﬁcance of dynamic MR has not been validated in non-
ischemic cardiomyopathy.Impact on clinical decision-making
 The management of patients with secondary MR is
challenging.69 For moderate-severe secondary MR and
LV dysfunction, coronary disease and myocardial
viability should be evaluated to consider revasculariza-
tion options (ACC/AHA class I).1
 Severe secondary MR is not usually improved by
revascularization alone and, according to ESC/EACTS
and ACC/AHA (class IIa) guidelines, should be
addressed during coronary bypass surgery.1,2
 Management of patients with moderate MR is controver-
sial. The ESC/EACTS guidelines recommend the use of
ESE to assess dyspnea, MR severity and SPAP (class IIa).2
 A signiﬁcant exercise-induced increase of MR (EROA 
13 mm2) identiﬁes patients at high risk who could
possibly beneﬁt from mitral intervention concomitant
with surgical revascularization. Conversely, patients with
mild-moderate MR with only mild exercise-induced
increase in MR might be treated more conservatively.
These recommendations need to be validated in a large
prospective trial.Right-Sided Valvular Heart Disease
There are no solid data regarding exercise testing or ESE
for prognosis or decision-making in right-sided VHD. Car-
diovascular magnetic resonance imaging (CMR) has some
applications for VHD.70 CMR can identify regional71 or
diffuse ﬁbrosis72 in patients with AS and evaluate viability
before revascularization.73 Stress CMR for evaluating VHD is
in its early stages of development and has focused on right-
sided VHD, relying on imaging techniques used for detec-
tion of CAD.74 Stress CMR may be performed with either
supine ergometer exercise75,76 or intravenous inotropes, usu-
ally dobutamine using a graded protocol.77,78 Ergometer stress
CMR is challenging because of motion artifacts.Pulmonary Stenosis and Regurgitation
Lurz et al. studied 17 patients with signiﬁcant pulmonary
regurgitation (PR) or stenosis who underwent percutaneous
pulmonary valve replacement.76 Patients performed supine
ergometer (1-2 W increments per minute) before and 1
month after intervention. Real-time CMR images were ob-
tained at rest and every 3 minutes during exercise to measure
end-diastolic, end-systolic, and stroke volumes. The study
showed that only after percutaneous pulmonary valve
replacement could patients with signiﬁcant PR or pulmonary
stenosis increase total stroke volume with exercise.76
Roest et al. performed supine ergometer stress CMR at
60% of peak oxygen consumption in 15 patients with cor-
rected Tetralogy of Fallot and PR.79 They observed an
abnormal response of the RV during exercise, suggesting that
chronic volume overload from PR might have a deleterious
effect on RV function.79
Valverde et al. performed dobutamine stress CMR in 18
patients with repaired Tetralogy of Fallot and severe PR.77
They compared pulmonary valve RVol and fraction at rest
and at stress using volumetric and phase-contrast ﬂow mea-
surements. The authors caution that RVol and fraction using
Figure 6. Doppler ﬁndings in a symptomatic patient with mild-moderate secondary MR and unmeasurable SPAP because of absence of tricuspid
regurgitation at rest (A). With exercise, a signiﬁcant increase of MR (ERO  13 mm2) associated with PHT (B) are shown. ERO, effective regurgitant
oriﬁce; EROA, ERO area; maxPG, maximal pressure gradient; MR, mitral regurgitation; PHT, pulmonary hypertension; RV, right ventricular; SPAP,
systolic pulmonary artery pressure; TTG, trans-tricuspid gradient; Vmax, maximal velocity; VTI, velocity time integral.
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stress, and should not be used interchangeably.77
Small studies in patients with congenital heart disease
indicate that stress CMR is feasible and safe, although it has
not yet been shown to inﬂuence clinical management.
Combination of rest and stress CMR might grow into a
comprehensive option for the evaluation of VHD.
Conclusions
Although the strongest recommendations for surgery
continue to be based on symptoms and resting LV repercussions,
recent studies have conﬁrmed the additive prognostic value of
the assessment of exercise-induced symptoms and exercise ca-
pacity, and evaluation of the dynamic components of VHD
using stress imaging, particularly echocardiography. Stress im-
aging can be useful to optimize risk stratiﬁcation and timing of
surgery in VHD. Randomized clinical trials are required to
conﬁrm that clinical decision-making based on stress imaging for
VHD leads to improved outcomes.Funding Sources
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